Amgen
Thousand Oaks · Founded 1980
About Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
Company Facts
- Founded: 1980
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $28.5B
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2022)
- Ticker: nasdaq:AMGN
- Website: amgen.com
- Phone: +1-(805)447-1000
Industries & Categories
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amgen-43557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.